## ALL: Allstate Corporation (The) - XLF: Financial Services

### Executive Summary

VALUE thesis: PEG 1.19 indicates fundamental undervaluation. Quality metrics strong (ROE 34%). Consistent execution (4/4 quarters beat estimates). Caution: momentum weakening (-4.1% MRS).

- **Horizon:** 20-60 days (position)
- **Risk Profile:** Lower - fundamental undervaluation
- **Stop Type:** Fixed 2xATR ($193.77)
- **If Wrong:** Exit if fundamentals deteriorate or stop hit
- **Invalidation:** PEG > 1.5 or earnings miss

### News

- **Articles:** 5
- **Sentiment:** Neutral (Bullish: 0, Bearish: 0)

**1. How Is The Hartford's Stock Performance Compared to Other Property & Casualty Insurance Stocks?**
- Source: Markets Financial Content | 20251208T121010 | Neutral | Relevance: 74%
-  The Hartford Insurance Group (HIG) has demonstrated strong year-to-date and 52-week stock performance, outperforming the Invesco KBW Property & Casualty Insurance ETF (KBWP). Despite a recent dip from its 52-week high, analysts maintain a "Moderate Buy" rating, anticipating further upside. The company's Q3 2025 profit surge and strong underwriting results illustrate its financial health and growth trajectory.

**2. How Is The Hartford's Stock Performance Compared to Other Property & Casualty Insurance Stocks?**
- Source: Palmetto Grain Brokerage | 20251208T130814 | Neutral | Relevance: 68%
-  The Hartford Insurance Group, Inc. (HIG) has seen its stock outperform the Invesco KBW Property & Casualty Insurance ETF (KBWP) and rival The Allstate Corporation (ALL) over the past year. Despite a recent dip from its 52-week high, HIG reported a strong 41% jump in Q3 2025 profit and has a "Moderate Buy" consensus rating from analysts, with a significant upside to its price target.

**3. Franklin Resources Inc. Sells 81,639 Shares of The Hackett Group, Inc. $HCKT**
- Source: MarketBeat | 20251207T095555 | Somewhat-Bullish | Relevance: 64%
-  Franklin Resources Inc. significantly reduced its stake in The Hackett Group, selling 81,639 shares and retaining 37,013 shares. Despite this sale, several other institutional investors increased their holdings, bringing institutional ownership to 78.12% of HCKT stock. The Hackett Group trades near $19.43 with a "Moderate Buy" consensus rating and a 2.5% dividend yield, though it has a high P/E ratio and payout ratio.

**4. Federated Hermes Inc. Increases Position in The Travelers Companies, Inc. $TRV**
- Source: MarketBeat | 20251207T121229 | Neutral | Relevance: 61%
- Federated Hermes Inc. increased its stake in The Travelers Companies by 8.5% in the second quarter, acquiring 63,445 shares to hold 806,535 shares valued at approximately $215.78 million. Despite the company beating earnings and revenue estimates in its latest quarter, the consensus analyst rating remains "Hold" with an average target price of $292.73. Travelers also announced a quarterly dividend of $1.10 per share, while insiders sold approximately 46,295 shares worth around $13.0 million over the past 90 days.

**5. Progressive Insurance (NYSE: PGR) taps Best Egg to expand access to flexible personal loans**
- Source: Stock Titan | 20251209T140153 | Neutral | Relevance: 58%
-  Progressive Insurance and Best Egg have expanded their partnership to offer Best Egg's personal loan solutions through Progressive's customer ecosystem. This collaboration aims to provide millions of customers with access to unsecured and secured personal loans for various financial needs, enhancing customer engagement and product breadth. The initiative seeks to reduce financial stress and empower individuals by offering convenient access to funds.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 3, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-11-26 | Roth Capital | $240 | $230 | +4% |
| 2025-11-11 | Keefe, Bruyette | $250 | $246 | +2% |
| 2025-11-10 | UBS | $255 | $250 | +2% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-11-26 | Roth Capital | main | Buy |
| 2025-11-11 | Keefe, Bruyette | main | Outperform |
| 2025-11-10 | UBS | main | Buy |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 8 ($0.12M) |
| Sells | 12 ($11.17M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 41.8% |
| Smart Money | **BEARISH** |
| Net Flow | 0.0% |
| Buying/Selling | 2 / 8 |

**Top Holders:**
- Vanguard Group Inc: 12.7% (-0.3%)
- Blackrock Inc.: 8.5% (-1.0%)
- Price (T.Rowe) Assoc: 4.9% (-17.0%)
- State Street Corpora: 4.5% (+0.7%)
- Geode Capital Manage: 2.7% (+3.3%)

### Key Risks

1. Momentum deterioration: MRS_20 falling (-4.1% 5d) with bearish MACD, trend may be turning.
2. Heavy insider selling: $11M sold (12 transactions in 90 days).
3. Market regime shift could impact momentum names disproportionately.

### Catalysts

- Analyst target momentum: 3 raises (avg +3%) could attract flows.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 1.19 suggests fair value with growth premium. Quality metrics strong (ROE 34%). Balance sheet: strong liquidity (30938000000.0x), $3.2B free cash flow. Insider selling cluster ($11.2M in 90 days), potential headwind. Institutional flow bearish (8 selling vs 2 buying).

| Metric | Value |
|--------|-------|
| Market Cap | $53.0B |
| Beta | 0.25 |
| 52W Range | $176.00 - $215.89 |
| Short Interest | 1.5% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.19 |
| Forward P/E | 8.3 |
| Current P/E | 7.0 |
| YoY Growth | -15.5% |
| EPS Direction | RISING |

### Technicals

MRS_20 deteriorating from -1.9% to -6.0% (-4.1% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 10.0pp (needs >4.0% for momentum thesis). AM_20 at -3.9% indicates price below own 20MA trend. Underperforming sector by 5.0pp, stock-specific weakness. Below SMA200 (1.00x), long-term trend not supportive. MACD histogram bearish (-1.58), momentum weakening.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -6.02% (CS: 11) | Weak |
| RSI_14 | 39.4 | Neutral |
| MACD Histogram | -1.58 | Bearish |
| vs SMA20 | 0.960x | Below |
| vs SMA50 | 0.986x | Below |
| vs SMA200 | 0.997x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** VALUE

### Trade Setup

- **Entry:** $201.05
- **Stop Loss:** $193.77 (3.6% risk)
- **Target:** $215.61 (R:R method)
- **Risk/Reward:** 2.00:1
- **Target Reasoning:** VALUE thesis targets 2.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 68
- **Position Value:** $13,671.40
- **Portfolio %:** 13.67%
- **Risk Dollars:** $500.00
- **Risk Per Trade:** 0.50%
- **Modifiers:** L1 100% | L2 50% | Combined 0.50x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | AVOID (Zone C) | 0.50x |

*NORMAL regime with moderate risk appetite. VIX remains in the mid-range, breadth is moderate, and yield curve is flat but not invertedâ€”indicating standard late-cycle conditions. Upbeat earnings and positive tech momentum are offset by cautious guidance in consumer sectors, suggesting selective positioning is favored.*

### Earnings

**Next:** 2026-02-04 (Est: $8.25)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $7.54 | $11.17 | +48.1% |
| 2025Q2 | $3.26 | $5.94 | +82.4% |
| 2025Q1 | $2.53 | $3.53 | +39.3% |
| 2024Q4 | $6.28 | $7.67 | +22.1% |

---
*RULE-based L3 | 2026-01-06 16:36 | MRS_20*